This document summarizes opportunities in the market for sexually transmitted disease (STD) testing. It notes that 33% of people with STDs are detected too late currently. While institutions can offer cheaper STD tests than traditional blood tests, reaching older populations requires selling testing packages in pharmacies. The main competition is traditional STD testing methods, but the document argues institutions will shift to cheaper rapid tests, helping increase awareness and lower healthcare costs with an healthier population.